Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Latvia

Latvia Articles

Industry

Latvian pharmaceutical company Grindeks has announced plans to increase revenues by over 30% in 2010 to LVL30mn (US$132mn), with a strategy of strengthening its position in current... 2010-04-27


Industry

Latvian pharmaceutical company Olainfarm has announced plans to open a representative office in Bangkok during 2010, while also expanding into Central Asian markets. BMI considers... 2010-03-15


BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15


More ARTICLES

Industry

BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected... 2010-01-05


Industry

BMI believes that pharmaceutical sales in Latvia is likely to be the worst hit among our 71-country pharmaceutical market universe. Data over the first 10 months of 2009 varies, although... 2009-12-24


Industry

BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings.... 2009-10-30


Industry

Pharmaceutical sales in the Baltic States continue to be heavily affected by the economic crisis, as six-month data for the early part of 2009 show contractions in Latvia and Lithuania,... 2009-09-30


Industry

Pharmaceuticals sales in Latvia showed negative year-on-year (y-o-y) growth during the second quarter of 2008, concurrent with the release of abysmal GDP data and rocketing unemployment.... 2009-09-02

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries